Aptose Biosciences's market cap is currently $4.28M. The company's EPS TTM is C$-3.8100549444; its P/E ratio is ―; Aptose Biosciences is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
